Coiffier B, Osmanov EA, Hong X, Scheliga A, Mayer J, Offner F, et al. Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab- sensitive, follicular lymphoma: a randomised phase 3 trial. Lancet Oncol 2011;12:773-84....
Rituximab for treat- ment of chemoimmunotherapy naive marginal zone lymphoma. Leuk Lymphoma 2007; 48: 1630-2.Lossos IS, Morgensztern D, Blaya M, Alencar A, Pereira D, Rosenblatt J. Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphoma. Leuk Lymphoma 2007; 48: 1630-1632 ...
“Acalabrutinib plus venetoclax and rituximab is a promising, highly effective, and well-tolerated chemotherapy-free treatment option for patients with treatment-naive MCL,” lead study author Michael Wang, MD, and colleagues wrote in a publication ...
Our aim was to compare an AntiCD20 therapy (rituximab) for rheumatoid arthritis in two patient populations (Group 1), anti-TNFα naïve patients and inadequate responders to Anti-TNFα therapy (Group 2).We analyzed the efficacy of the drug Rituximab (RTX) in RA patients who failed methotrex...
Bortezomib + Rituximab Shows Benefit in Patients With Relapsed, RituximabNaive or Sensitive Follicular Lymphoma vs Rituximab AloneDebra Hughes
We present the long-term follow-up of a prospective, phase II clinical trial that evaluated the combination of ixazomib, dexamethasone, and rituximab (IDR) in 26 treatment-naive patients with WM. IDR was administered as 6 monthly induction cycles followed by 6 every-2-month maintenance cycles....
Rituximab alone is as effective as associated with steroids on naive patients with generalized myasthenia gravisUNIVERSITY hospitalsRITUXIMABINTRAVENOUS immunoglobulinsPLASMAPHERESISCORTICOSTEROIDSIntroduction: Rituximab (RTX) has been proven effective in managing refractory generalized myasthenia gravis (MG), and ...
Conclusions Our study confirms the effectiveness of rituximab in RA patients and suggests a higher magnitude of response in naive biological patients at 6 months of RTX therapy. These findings put in perspective an extension of rituximab as a first-line biologic for RA treatment. Disclosure of ...
Rituximab improved physical function and quality of life in patients with early rheumatoid arthritis: results from randomized active comparator placebo- controlled trial of rituximab in combination with methotrexate compared to methotrexate alone in patients naive to methotrexate (Image...
Rigby W, Ferraccioli G, Greenwald M, et al. Rituximab improved physical function and quality of life in patients with rheumatoid arthritis naive to methotrexate (IMAGE study). Arthritis Care Res (Hoboken) 2010. In press.Rigby W, Ferraccioli G, Greenwald M, et al. Ri...